Regulatory

Source: Ecancer News, January 2019 The Food and Drug Administration has granted accelerated approval to pembrolizumab for adult and paediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma (MCC).…

Source: Pharma Times, January 2019 The guidelines apply to adults who have disease that has spread to the lymph nodes and who have already had surgery to remove the tumour…

Source: The Washington Post, January 2019 The Food and Drug Administration on Monday approved a drug for a wide range of cancers based on a shared mutation, rather than the…

Source: Immuno-oncology News, December 2018 The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency (EMA), has recommended the approval of Keytruda(pembrolizumab) for the treatment of…